Inaktiver Wert

Rennova Health Inc Aktie Nasdaq

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24.07.20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17.07.20
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08.07.20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29.06.20
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16.06.20

Manager	Titel	Alter	Seit
Darrell Peterson CEO	Chief Executive Officer	65	14.05.23
Gerard Dab CHM	Chairman	75	14.05.23
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Aufsichtsräte	Titel	Alter	Seit
Gerard Dab CHM	Chairman	75	14.05.23
Sharon Hollis CEO	Chief Executive Officer	47	01.07.11
Francisco Roca BRD	Director/Board Member	58	14.05.23

Sektor

	% 1. Jan.	Kap.
SONIC HEALTHCARE LIMITED	-18.58%	8.3 Mrd.
RADNET, INC.	+47.25%	3.78 Mrd.
SYNLAB AG	-8.58%	2.47 Mrd.
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-38.71%	2.46 Mrd.
DR. LAL PATHLABS LIMITED	-10.06%	2.31 Mrd.
NEOGENOMICS, INC.	-5.44%	1.95 Mrd.
FLEURY S.A.	-17.79%	1.59 Mrd.
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.78%	1.21 Mrd.
METROPOLIS HEALTHCARE LIMITED	+6.69%	1.1 Mrd.